In that study, an alteration of the rsfMRI networks in AD mice was observed initially solely in the DMN at 2 months of APP overexpression—when Aβ plaques were absent—but soluble Aβ was increased by 20-fold. The gene discussed is APP; the disease is Alzheimer disease.